{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:43:12Z","timestamp":1791315792023,"version":"4.3.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Health Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Differentiating between primary CNS lymphomas (PCNSL) and secondary CNS lymphomas (SCNSL) remains a challenge in imaging. The aim of this study was to differentiate histopathologically-proven PCNSL and SCNSL by using 25 qualitative VASARI and five other MRI features.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>MRIs of 31 cases (19 PCNSL and 12 SCNSL) obtained between January 2010 and February 2022 were retrospectively reviewed. Two blinded readers independently evaluated images without knowledge of clinical data or whether CNS lymphoma was primary or secondary. The findings of each reader were recorded to assess interreader agreement. The results of two readers were evaluated by a senior neuroradiologist to reach a consensus. A statistical analysis was performed on the collected data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Most VASARI features showed no statistically significant differences between the two groups, except for two features. Tumor location exhibited a statistically different distribution between PCNSL and SCNSL groups (<jats:italic>p<\/jats:italic>\u2009=\u20090.036). Proportion of edema was greater in the PCNSL group compared to the SCNSL group (<jats:italic>p<\/jats:italic>\u2009=\u20090.049). Among other MRI features, infratentorial involvement was more frequent in the SCNSL group (<jats:italic>p<\/jats:italic>\u2009=\u20090.014), while notch sign was more commonly detected in the PCNSL group (<jats:italic>p<\/jats:italic>\u2009=\u20090.027). Inter-reader agreement for VASARI features ranged from moderate to almost perfect, and for other MRI features, it ranged from fair to almost perfect.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Despite the challenges in distinguishing imaging features of PCNSL and SCNSL; frontal lobe location, a higher proportion of edema and the presence of a notch sign may indicate PCNSL, while infratentorial involvement may suggest SCNSL.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00234-025-03594-1","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T06:31:34Z","timestamp":1742193094000},"page":"1411-1421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Qualitative MRI features in the differentiation between primary and secondary CNS lymphoma"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7878-6117","authenticated-orcid":false,"given":"Yusuf Kenan","family":"Cetinoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2207-5850","authenticated-orcid":false,"given":"Kaz\u0131m Ayberk","family":"Sinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5564-2196","authenticated-orcid":false,"given":"Merve","family":"Horoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1263-0918","authenticated-orcid":false,"given":"Faz\u0131l","family":"Gelal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"3594_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G et al (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2011\u20132015. Neuro Oncol 20:1\u201386. https:\/\/doi.org\/10.1093\/neuonc\/noy131","journal-title":"Neuro Oncol"},{"key":"3594_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1215\/S1522851705000323","volume":"8","author":"S Hoffman","year":"2006","unstructured":"Hoffman S, Propp JM, McCarthy BJ (2006) Temporal trends in incidence of primary brain tumors in the united States, 1985\u20131999. Neuro Oncol 8:27\u201337. https:\/\/doi.org\/10.1215\/S1522851705000323","journal-title":"Neuro Oncol"},{"key":"3594_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ejrad.2010.01.017","volume":"79","author":"E Senocak","year":"2011","unstructured":"Senocak E, Oguz KK, Ozgen B et al (2011) Parenchymal lymphoma of the brain on initial MR imaging: A comparative study between primary and secondary brain lymphoma. Eur J Radiol 79:288\u2013294. https:\/\/doi.org\/10.1016\/j.ejrad.2010.01.017","journal-title":"Eur J Radiol"},{"key":"3594_CR4","first-page":"318","volume":"37","author":"E Koubska","year":"2016","unstructured":"Koubska E, Weichet J, Malikova H (2016) Central nervous system lymphoma: A morphological MRI study. Neuroendocrinol Lett 37:318\u2013324","journal-title":"Neuroendocrinol Lett"},{"key":"3594_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2147\/NDT.S157959","volume":"14","author":"H Malikova","year":"2018","unstructured":"Malikova H, Burghardtova M, Koubska E et al (2018) Secondary central nervous system lymphoma: spectrum of morphological MRI appearances. Neuropsychiatr Dis Treat 14:733\u2013740. https:\/\/doi.org\/10.2147\/NDT.S157959","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3594_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.blre.2006.02.001","volume":"20","author":"QA Hill","year":"2006","unstructured":"Hill QA, Owen RG (2006) CNS prophylaxis in lymphoma: who to target and what therapy to use. Blood Rev 20:319\u2013332. https:\/\/doi.org\/10.1016\/j.blre.2006.02.001","journal-title":"Blood Rev"},{"key":"3594_CR7","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3174\/ajnr.A2171","volume":"32","author":"IS Haldorsen","year":"2011","unstructured":"Haldorsen IS, Espeland A, Larsson EM (2011) Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. Am J Neuroradiol 32:984\u2013992. https:\/\/doi.org\/10.3174\/ajnr.a2171","journal-title":"Am J Neuroradiol"},{"key":"3594_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11060-014-1379-4","volume":"117","author":"Y Iwadate","year":"2014","unstructured":"Iwadate Y, Suganami A, Ikegami S et al (2014) Non-deep-seated primary CNS lymphoma: therapeutic responses and a molecular signature. J Neurooncol 117:261\u2013268. https:\/\/doi.org\/10.1007\/s11060-014-1379-4","journal-title":"J Neurooncol"},{"key":"3594_CR9","doi-asserted-by":"publisher","unstructured":"Abrey LE, Batchelor TT, Ferreri AJM et al (2005) Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 23:5034\u20135043. https:\/\/doi.org\/10.1200\/JCO.2005.13.524","DOI":"10.1200\/JCO.2005.13.524"},{"key":"3594_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1182\/asheducation-2017.1.565","volume":"2017","author":"AJM Ferreri","year":"2017","unstructured":"Ferreri AJM (2017) Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents. Hematology 2017:565\u2013577. https:\/\/doi.org\/10.1182\/asheducation-2017.1.565","journal-title":"Hematology"},{"key":"3594_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0090-3019(99)00186-X","volume":"53","author":"S Yoshida","year":"2000","unstructured":"Yoshida S, Morii K, Watanabe M, Saito T (2000) Characteristic features of malignant lymphoma with central nervous system involvement. Surg Neurol 53:163\u2013167. https:\/\/doi.org\/10.1016\/S0090-3019(99)00186-X","journal-title":"Surg Neurol"},{"key":"3594_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/10428190802311441","volume":"49","author":"J Rubenstein","year":"2008","unstructured":"Rubenstein J, Ferreri AJM, Pittaluga S (2008) Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment. Leuk Lymphoma 49:43\u201351. https:\/\/doi.org\/10.1080\/10428190802311441","journal-title":"Leuk Lymphoma"},{"key":"3594_CR13","unstructured":"TCGA Glioma Phenotype Research Group (2020) VASARI Research Project. https:\/\/wiki.cancerimagingarchive.net\/display\/Public\/VASARI+Research+Project. Accessed 25 Apr 2022"},{"key":"3594_CR14","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1148\/radiol.13120118","volume":"267","author":"DA Gutman","year":"2013","unstructured":"Gutman DA, Cooper LAD, Hwang SN et al (2013) MR imaging predictors of molecular profile and survival: Multi-institutional study of the TCGA glioblastoma data set. Radiology 267:560\u2013569. https:\/\/doi.org\/10.1148\/radiol.13120118","journal-title":"Radiology"},{"key":"3594_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ejrad.2019.03.003","volume":"114","author":"H Hyare","year":"2019","unstructured":"Hyare H, Rice L, Thust S et al (2019) Modelling MR and clinical features in grade II\/III Astrocytomas to predict IDH mutation status. Eur J Radiol 114:120\u2013127. https:\/\/doi.org\/10.1016\/j.ejrad.2019.03.003","journal-title":"Eur J Radiol"},{"key":"3594_CR16","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.acra.2018.12.016","volume":"26","author":"X Chen","year":"2019","unstructured":"Chen X, Fang M, Dong D et al (2019) Development and validation of a MRI-Based radiomics prognostic classifier in patients with primary glioblastoma multiforme. Acad Radiol 26:1292\u20131300. https:\/\/doi.org\/10.1016\/j.acra.2018.12.016","journal-title":"Acad Radiol"},{"key":"3594_CR17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1148\/radiol.14131731","volume":"273","author":"O Gevaert","year":"2014","unstructured":"Gevaert O, Mitchell LA, Achrol AS et al (2014) Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features. Radiology 273:168\u2013164. https:\/\/doi.org\/10.1148\/radiol.14131731","journal-title":"Radiology"},{"key":"3594_CR18","doi-asserted-by":"publisher","unstructured":"Meier R, Pahud de Mortanges A, Wiest R, Knecht U (2020) Exploratory analysis of qualitative MR imaging features for the differentiation of glioblastoma and brain metastases. Front Oncol 10. https:\/\/doi.org\/10.3389\/fonc.2020.581037","DOI":"10.3389\/fonc.2020.581037"},{"key":"3594_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3174\/ajnr.A7795","volume":"44","author":"A Pons-Escoda","year":"2023","unstructured":"Pons-Escoda A, Naval-Baudin P, Velasco R et al (2023) Imaging of lymphomas involving the CNS: an Update-Review of the full spectrum of disease with an emphasis on the world health organization classifications of CNS tumors 2021 and hematolymphoid tumors 2022. Am J Neuroradiol 44:358\u2013366. https:\/\/doi.org\/10.3174\/ajnr.A7795","journal-title":"Am J Neuroradiol"},{"key":"3594_CR20","doi-asserted-by":"publisher","first-page":"CNS67","DOI":"10.2217\/cns-2020-0020","volume":"10","author":"S Bowden","year":"2020","unstructured":"Bowden S, Munger D, Thiessen J et al (2020) The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series. CNS Oncol 10:CNS67. https:\/\/doi.org\/10.2217\/cns-2020-0020","journal-title":"CNS Oncol"},{"key":"3594_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.17712\/nsj.2015.4.20150125","volume":"20","author":"H Chen","year":"2015","unstructured":"Chen H, Dong H (2015) A rare case of nonenhancing primary central nervous system lymphoma mimic multiple sclerosis. Neurosciences J 20:380. https:\/\/doi.org\/10.17712\/nsj.2015.4.20150125","journal-title":"Neurosciences J"},{"key":"3594_CR22","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3174\/ajnr.A6025","volume":"40","author":"A Lasocki","year":"2019","unstructured":"Lasocki A, Gaillard F (2019) Non-Contrast-Enhancing tumor: A new frontier in glioblastoma research. Am J Neuroradiol 40:758. https:\/\/doi.org\/10.3174\/ajnr.A6025","journal-title":"Am J Neuroradiol"},{"key":"3594_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3348\/kjr.2010.11.3.269","volume":"11","author":"D Zhang","year":"2010","unstructured":"Zhang D, Hu LB, Henning TD et al (2010) MRI findings of primary CNS lymphoma in 26 immunocompetent patients. Korean J Radiol 11:269\u2013277. https:\/\/doi.org\/10.3348\/kjr.2010.11.3.269","journal-title":"Korean J Radiol"},{"key":"3594_CR24","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1148\/radiographics.16.6.8946545","volume":"16","author":"JH Rees","year":"1996","unstructured":"Rees JH, Smirniotopoulos JG, Jones R, v, Wong K (1996) Glioblastoma multiforme: radiologic-pathologic correlation. Radiographics 16:1413\u20131438. https:\/\/doi.org\/10.1148\/radiographics.16.6.8946545","journal-title":"Radiographics"},{"key":"3594_CR25","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3174\/ajnr.A1447","volume":"30","author":"IS Haldorsen","year":"2009","unstructured":"Haldorsen IS, Kr\u00e5kenes J, Krossnes BK et al (2009) CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989\u20132003. Am J Neuroradiol 30:744\u2013751. https:\/\/doi.org\/10.3174\/ajnr.A1447","journal-title":"Am J Neuroradiol"},{"key":"3594_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12883-019-1511-3","volume":"19","author":"Y Wu","year":"2019","unstructured":"Wu Y, Wang Y, Sun X et al (2019) Parenchymal central nervous system involvement in aggressive B-cell lymphoma: retrospective analysis of clinical and MRI features in a Chinese population. BMC Neurol 19:268. https:\/\/doi.org\/10.1186\/s12883-019-1511-3","journal-title":"BMC Neurol"},{"key":"3594_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1470-7330-14-22","volume":"14","author":"A Mansour","year":"2014","unstructured":"Mansour A, Qandeel M, Abdel-Razeq H, Abu Ali HA (2014) MR imaging features of intracranial primary CNS lymphoma in immune competent patients. Cancer Imaging 14:22. https:\/\/doi.org\/10.1186\/1470-7330-14-22","journal-title":"Cancer Imaging"},{"key":"3594_CR28","doi-asserted-by":"publisher","first-page":"R1256","DOI":"10.1016\/j.cub.2018.09.017","volume":"28","author":"MA Silver","year":"2018","unstructured":"Silver MA (2018) Cognitive neuroscience: functional specialization in human cerebellum. Curr Biol 28:R1256\u2013R1258. https:\/\/doi.org\/10.1016\/j.cub.2018.09.017","journal-title":"Curr Biol"},{"key":"3594_CR29","doi-asserted-by":"publisher","unstructured":"Sereno MI, Diedrichsen J, Tachrount M et al (2020) The human cerebellum has almost 80% of the surface area of the neocortex. Proceedings of the National Academy of Sciences 117:19538\u201319543. https:\/\/doi.org\/10.1073\/pnas.2002896117","DOI":"10.1073\/pnas.2002896117"},{"key":"3594_CR30","doi-asserted-by":"publisher","unstructured":"Solar P, Hendrych M, Barak M et al (2022) Blood-Brain barrier alterations and edema formation in different brain mass lesions. Front Cell Neurosci 16. https:\/\/doi.org\/10.3389\/fncel.2022.922181","DOI":"10.3389\/fncel.2022.922181"},{"key":"3594_CR31","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3109\/02841869609084002","volume":"35","author":"N Keldsen","year":"1996","unstructured":"Keldsen N, Michalski W, Bentzen SM et al (1996) Risk factors for central nervous system involvement in Non-Hodgkins-Lymphoma a multivariate analysis. Acta Oncol (Madr) 35:703\u2013708. https:\/\/doi.org\/10.3109\/02841869609084002","journal-title":"Acta Oncol (Madr)"},{"key":"3594_CR32","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/annonc\/mdf175","volume":"13","author":"A Hollender","year":"2002","unstructured":"Hollender A, Kvaloy S, Nome O et al (2002) Central nervous system involvement following diagnosis ofnon-Hodgkin\u2019s lymphoma: a risk model. Ann Oncol 13:1099\u20131107. https:\/\/doi.org\/10.1093\/annonc\/mdf175","journal-title":"Ann Oncol"},{"key":"3594_CR33","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1182\/blood.V91.4.1178","volume":"91","author":"K van Besien","year":"1998","unstructured":"van Besien K, Ha CS, Murphy S et al (1998) Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood 91:1178\u20131184. https:\/\/doi.org\/10.1182\/blood.V91.4.1178","journal-title":"Blood"},{"key":"3594_CR34","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3109\/10428199909058415","volume":"32","author":"PL Zinzani","year":"1999","unstructured":"Zinzani PL, Magagnoli M, Frezza G et al (1999) Isolated central nervous system relapse in aggressive Non-Hodgkin\u2019s lymphoma: the Bologna experience. Leuk Lymphoma 32:571\u2013576. https:\/\/doi.org\/10.3109\/10428199909058415","journal-title":"Leuk Lymphoma"},{"key":"3594_CR35","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.surneu.2005.08.027","volume":"65","author":"NL Grupka","year":"2006","unstructured":"Grupka NL, Seinfeld J, Ryder J et al (2006) Secondary central nervous system involvement by follicular lymphoma: case report and review of the literature. Surg Neurol 65:590\u2013594. https:\/\/doi.org\/10.1016\/j.surneu.2005.08.027","journal-title":"Surg Neurol"},{"key":"3594_CR36","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3174\/ajnr.A7399","volume":"43","author":"A Biswas","year":"2022","unstructured":"Biswas A, Amirabadi A, Wagner MW, Ertl-Wagner BB (2022) Features of visually accesable Rembrandt images: interrater reliability in pediatric brain tumors. Am J Neuroradiol 43:304\u2013308. https:\/\/doi.org\/10.3174\/ajnr.A7399","journal-title":"Am J Neuroradiol"},{"key":"3594_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40644-023-00638-8","volume":"24","author":"NH Setyawan","year":"2024","unstructured":"Setyawan NH, Choridah L, Nugroho HA et al (2024) Beyond invasive biopsies: using VASARI MRI features to predict grade and molecular parameters in gliomas. Cancer Imaging 24:3. https:\/\/doi.org\/10.1186\/s40644-023-00638-8","journal-title":"Cancer Imaging"}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-025-03594-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00234-025-03594-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-025-03594-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T07:52:29Z","timestamp":1757145149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00234-025-03594-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3594"],"URL":"https:\/\/doi.org\/10.1007\/s00234-025-03594-1","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"value":"0028-3940","type":"print"},{"value":"1432-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"19 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board approval was obtained from the Non-Invasive Clinical Research Ethics Committee of \u0130zmir K\u00e2tip \u00c7elebi University with the application number 2023-GOKAE-0411 for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Since the study was retrospective, informed consent was not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"There is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}